How is corticotropin different from taking a corticosteroid like prednisone?

Prednisone replaces missing cortisol directly, and high doses can suppress your pituitary's natural ACTH production, potentially weakening your adrenal glands further. Corticotropin stimulates your adrenal glands to produce cortisol themselves, preserving your natural hormone axis and feedback loops. This distinction matters most in adrenal insufficiency, where maintaining gland function is clinically important. Corticotropin must be injected; corticosteroids can be taken by mouth.

Why is corticotropin used for infantile spasms when other seizure drugs exist?

[Clinical evidence](https://pubmed.ncbi.nlm.nih.gov/18490393) shows corticotropin has superior efficacy for West syndrome (infantile spasms) compared to standard anticonvulsants, with response rates around 50-90%. Its mechanism appears to combine cortisol-mediated and direct immune-modulating effects on brain inflammation. It remains a first-line therapy because seizure suppression is critical for neurodevelopment in infants, and corticotropin achieves this better than alternatives.

How long does a corticotropin injection last?

Natural ACTH has a 15-minute half-life, but pharmaceutical corticotropin is formulated as repository (zinc hydroxide) corticotropin, which extends duration to 24-72 hours. This allows practical dosing regimens, typically 1-3 injections per week depending on the condition. Peak cortisol levels occur 1-4 hours after injection and gradually decline thereafter.

Does corticotropin have immune effects beyond raising cortisol?

Yes. Melanocortin receptors exist on immune cells, and corticotropin binding them can shift cytokine profiles—reducing pro-inflammatory signals and promoting anti-inflammatory responses independently of cortisol elevation. This direct immunomodulation may explain corticotropin's effectiveness in infantile spasms and some autoimmune conditions where standard immunosuppressants fail.

Can corticotropin be used long-term for adrenal insufficiency?

Yes, but it requires careful monitoring. Prolonged corticotropin use carries similar side effects to any high-cortisol state: hyperglycemia, hypertension, osteoporosis, and infection risk. However, because corticotropin works via natural feedback loops, some patients tolerate it better than fixed-dose synthetic steroids. Regular laboratory monitoring of cortisol, electrolytes, and glucose is essential.

How Does Corticotropin Work? Mechanism Explained

Corticotropin (ACTH, or adrenocorticotropic hormone) is an FDA-approved peptide hormone that stimulates your adrenal glands to produce and release cortisol and other steroid hormones. It works by binding to melanocortin receptors on adrenal cells, triggering a cascade of biochemical events that boost cortisol output. First synthesized in the 1950s, corticotropin remains a cornerstone treatment for adrenal insufficiency and certain inflammatory conditions. Unlike corticosteroid drugs that replace cortisol directly, corticotropin reactivates your body's own hormone-producing machinery—a fundamentally different approach with distinct clinical advantages and safety considerations. With 185 clinical trials completed, corticotropin has robust evidence supporting its use in specific FDA-approved indications.

The Basic Mechanism: Adrenal Stimulation

Corticotropin's core action is elegant in its simplicity: it's a signalling molecule that tells your adrenal glands to "wake up" and produce cortisol. The adrenal cortex—the outer layer of your two adrenal glands—sits atop each kidney and manufactures several hormones crucial to stress response, metabolism, and immune function. Corticotropin is the brain's way of commanding these glands into action.

When you inject corticotropin, it travels through the bloodstream and binds to melanocortin-2 (MC2) receptors on the surface of adrenocortical cells. This binding is the molecular "on switch." Once activated, these receptors trigger an intracellular signalling pathway—specifically, the cAMP (cyclic adenosine monophosphate) cascade—that unlocks enzyme activity deep inside the adrenal cell. This ultimately tells mitochondria to convert cholesterol into pregnenolone, the starting material for all steroid hormone synthesis. The result: rapid, measurable increases in cortisol, aldosterone, and androgens in your bloodstream.

Why This Matters: The Difference From Steroid Replacement

This mechanism is fundamentally different from simply taking a corticosteroid tablet like prednisone or hydrocortisone. Those drugs replace missing cortisol; corticotropin stimulates your body to make it. The distinction has real clinical implications. When you use synthetic steroids, your pituitary senses the rising cortisol levels and shuts down its own ACTH production—a negative feedback loop that can suppress your adrenal glands further over time. Corticotropin, by contrast, maintains the integrity of your natural hormone axis and preserves adrenal responsiveness.

This is why corticotropin remains FDA-approved for primary adrenal insufficiency (Addison's disease) and secondary adrenal insufficiency, where the pituitary or hypothalamus has failed. For patients whose adrenal glands are intact but underactive, corticotropin can reawaken them. In some inflammatory conditions—like infantile spasms (West syndrome)—corticotropin's immunomodulatory effects appear to work through pathways distinct from simple cortisol elevation.

The Immune and Anti-Inflammatory Effects

Beyond adrenal stimulation, corticotropin has direct immune effects that researchers are still unpacking. Melanocortin receptors exist on immune cells, including macrophages and T cells, suggesting corticotropin may dampen inflammation through channels independent of cortisol production. When corticotropin binds MC3 and MC4 receptors on immune tissue, it can shift the cytokine profile—reducing pro-inflammatory signals like TNF-α and IL-1β while promoting anti-inflammatory responses.

This mechanism is particularly relevant in infantile spasms, a devastating seizure disorder in infants. Clinical trials have consistently shown corticotropin's superiority over other treatments for this condition, with response rates around 50-90% depending on the underlying etiology. The anti-seizure effect likely combines cortisol-mediated and immune-mediated pathways, making corticotropin a unique therapeutic option where standard anticonvulsants fail.

For comparison, consider how other peptide hormone therapies work differently. Alexamorelin, for example, stimulates growth hormone release via the ghrelin receptor—a distinct mechanism entirely. Similarly, abaloparatide targets parathyroid hormone receptors to promote bone formation. Corticotropin's specificity to adrenal function and immune modulation makes it a niche but powerful tool.

Pharmacokinetics: How Long Does It Last?

Corticotropin is a 39-amino-acid peptide, which means it's vulnerable to enzymatic degradation. Natural ACTH has a half-life of roughly 15 minutes in circulation, making frequent dosing necessary for sustained effect. To extend its duration, pharmaceutical corticotropin is often formulated as corticotropin zinc hydroxide (repository corticotropin), which slows absorption and prolongs bioavailability to 24-72 hours depending on the dose and individual factors.

This slow-release mechanism means a single injection can sustain adrenal stimulation over days, allowing for practical outpatient therapy. Peak cortisol levels typically occur 1-4 hours post-injection, with gradual decline thereafter. The dosing regimen depends on the indication—infantile spasms require higher, more frequent dosing than maintenance therapy for adrenal insufficiency.

Unlike synthetic corticosteroids that can be taken orally, corticotropin's peptide structure means it must be injected (intramuscularly or intravenously). This is actually advantageous in some contexts: it reduces accidental overdose risk and allows clinicians to titrate doses more precisely. It also ensures absorption into the bloodstream without degradation by digestive enzymes—a challenge faced by peptide therapies like 5-Amino-1MQ, which require creative formulation strategies to overcome the gut barrier.

Clinical Efficacy: What the Evidence Shows

With 185 completed clinical trials on record, corticotropin has accumulated substantial evidence. In adrenal insufficiency, it restores the physiologic cortisol rhythm—ideally mimicking the body's natural diurnal pattern—in ways that fixed-dose steroid replacement cannot. Patients often report improved energy, reduced fatigue, and better stress tolerance when corticotropin reactivates their adrenal glands.

In infantile spasms, corticotropin or ACTH remains a first-line therapy alongside vigabatrin, with Class I evidence supporting its use. Response rates—defined as cessation of spasms—exceed 50% in many cohorts, and long-term neurodevelopmental outcomes are superior when seizures are arrested early. The mechanism here is still not fully understood, but the clinical benefit is undeniable.

For other inflammatory or autoimmune conditions—including certain cases of polymyalgia rheumatica, myasthenia gravis, or lupus—corticotropin has shown benefit in some studies, though it's less commonly used than conventional immunosuppressants. Its immune-modulating effects remain an area of active research.

Safety and Tolerability Considerations

Because corticotropin drives cortisol production, side effects broadly mirror those of steroid therapy: hyperglycemia, hypertension, mood changes, insomnia, and immunosuppression with prolonged use. However, because corticotropin works via the body's natural feedback loops, some patients tolerate it better than exogenous steroids. If cortisol rises too high, the feedback signal to the pituitary naturally dampens further ACTH release—a self-limiting mechanism absent in synthetic steroid administration.

That said, corticotropin is contraindicated in several settings: fungal infections, peptic ulcer disease, hypertension (unless carefully managed), and pregnancy are relative or absolute contraindications. Electrolyte monitoring is essential, particularly potassium and sodium, since corticotropin also stimulates aldosterone production, which affects fluid and mineral balance.

The Bigger Picture: Peptide Hormones in Modern Medicine

Corticotropin sits within a broader landscape of peptide therapeutics that exploit the body's native signalling systems. Like ACE-031, which inhibits activin signalling to promote muscle growth, or abarelix, which blocks GnRH to treat prostate cancer, corticotropin harnesses existing biology rather than imposing foreign chemistry. This approach—working with the body's endocrine axes rather than against them—represents a fundamental therapeutic philosophy that's gaining traction across endocrinology and immunology.

The FDA's continued approval of corticotropin, despite the availability of synthetic steroids, reflects its unique niche: situations where reactivating the natural axis is preferable to replacement therapy, or where direct immune effects matter. For infantile spasms in particular, corticotropin remains irreplaceable.

Key Takeaways

Corticotropin works by binding melanocortin receptors on adrenal cells, triggering cAMP signalling that unlocks cortisol and steroid hormone synthesis. Unlike exogenous steroids, it preserves the body's natural endocrine feedback loops and may offer direct immune-modulating benefits. With 185 clinical trials and robust FDA approval, corticotropin remains a cornerstone therapy for adrenal insufficiency and infantile spasms—a peptide hormone that exemplifies how tapping into the body's own signalling machinery can achieve powerful therapeutic effects.

How Does Corticotropin Work? The Complete Mechanism Explained